Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Elena Arrigoni

The Amount of Activating EGFR Mutations in Circulating Cell-Free DNA Is a Marker to Monitor Osimertinib Response

British Journal of Cancer

Cancer Research

English

KRAS Mutations and Its Implications for Acquired Resistance to Treatment in NSCLC

English

Related publications

P1.01-77 Osimertinib in the First-Line Treatment of Non-Small Cell Lung Cancer Harboring Activating EGFR Mutation From Circulating Tumor DNA

Journal of Thoracic Oncology

Respiratory Medicine

English

Detection of EGFR Mutations in Circulating Free DNA by PNA-mediated PCR Clamping

Journal of Experimental and Clinical Cancer Research

Cancer Research

English

P1.01-46 Circulating Tumor DNA Analysis for Predicting Response to Osimertinib and Disease Progression in EGFR-Mutant Non-Small-Cell Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

KRAS Mutations in Blood Circulating Cell-Free DNA: A Pancreatic Cancer Case-Control

English

Circulating Cell-Free DNA

English

Detection of Mutations in Circulating Cell‐free DNA in Relation to Disease Stage in Colorectal Cancer

Cancer Medicine

Cancer Research

Nuclear Medicine

English

Circulating Cell-Free DNA and Its Integrity as a Prognostic Marker for Breast Cancer

Multidisciplinary

English

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer

Frontiers in Genetics

Molecular Medicine

English

Circulating Cell Free DNA as the Diagnostic Marker for Colorectal Cancer: A Systematic Review and Meta-Analysis

English